Cassier, P A <br/><br/>
The histone deacetylase inhibitor panobinostat is active in patients with advanced pretreated ovarian sex-cord tumors.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  May 2014 
 - 1074-5 p.  digital 
<br/><br/> Publication Type: Letter; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdu045  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--pharmacology<br/>Clinical Trials, Phase II as Topic<br/>Female<br/>Histone Deacetylase Inhibitors--pharmacology<br/>Humans<br/>Hydroxamic Acids--pharmacology<br/>Indoles--pharmacology<br/>Middle Aged<br/>Ovarian Neoplasms--drug therapy<br/>Panobinostat<br/>Sex Cord-Gonadal Stromal Tumors--drug therapy<br/>Treatment Outcome